CADL (Candel) Pangali Forward P/E
Candel Therapeutics (CADL) focuses on developing innovative therapies for oncological pathologies. Price action on the GURU.Markets platform shows the current P/E multiple at 0.00. Business success relies on the trial results of drugs for prostate and brain cancer, as well as partnerships with medical centers. High barriers to entry are ensured by complex FDA requirements and strict patent protection of viral technologies.
Ringkesan rincian data analitis Candel (CADL)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Candel Therapeutics|CADL - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Candel Therapeutics|CADL - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Candel Therapeutics Inc.|CADL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Candel Therapeutics|Rasio cepet candeltx.com
- rincian asil keuangan lan kelipatan valuasi:
CADL - Bathi perusahaan|Proyeksi bathi mangsa ngarep Candel Therapeutics|CADL - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Candel Therapeutics|CADL - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Candel Therapeutics Inc.|CADL - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Candel Therapeutics|CADL - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan candeltx.com|CADL - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Candel Therapeutics
- indikator volume dodolan lan pendapatan:
Analisis fundamental perusahaan:Candel Therapeutics, Inc.
The indicator's formula is mathematically sensitive to the quality of expected cash flows and the cost of capital. This metric determines the price of future earnings, reflecting the market equilibrium between the demand for and supply of the asset. For Candel Therapeutics (CADL), the calculation is based on the potential of the CAN-2409 platform and FDA approvals. An analysis of the business's forward P/E allows for an assessment of the premium paid for future successes in immunotherapy. The curve's dynamics signal the issuer's liquidity.
Analisis perusahaan pesaing
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Corp DCTH|Pangali Forward P/E YMAB|Prakiraan rega marang bathi aurabiosciences.com AURA|Pangali Forward P/E ARAY (Accuray)|Pangali Forward P/E SELLAS Life Sciences Group, Inc. SLS|ACTU - Rega marang bathi mangsa ngarep|CTOR (Citius Oncology Inc) - Rasio rega marang bathi mangsa ngarep|HURA: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep TARA|FATE (Fate Therapeutics) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Aadi Bio WHWK|Rega marang bathi mangsa ngarep TScan Therapeutics (TCRX)|Rega marang bathi mangsa ngarep CSBR (championsoncology.com)|XBiotech - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CVM|OSTX: Prakiraan rega marang bathi|radiopharmtheranostics.com - Rasio kapitalisasi marang bathi mangsa ngarep|ARTV: Pangali Forward P/E|Adlai Nortye - Pangali mangsa ngarep rega marang bathi|VERU (Veru Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi tempesttx.com TPST|Rega marang bathi mangsa ngarep Xilio Therapeutics, Inc. (XLO)|RENB (renovarobio.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E MURA (Mural Oncology)|Pangali Forward P/E Kairos Pharma Limited KAPA|OKUR - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake GDTC|CRIS: Pangali Forward P/E|Rasio prakiraan rega marang bathi Apollomics (APLM)|Prakiraan rega marang bathi THAR|Pangali Forward P/E Advanced Biomed Corp|Prakiraan rega marang bathi GNPX (Genprex, Inc.)|Rasio kapitalisasi marang bathi mangsa ngarep CLDI|Pangali Forward P/E SBFM (Sunshine Biopharma, Inc.)|Kapitalisasi marang proyeksi bathi Xenetic Biosciences Inc. (XBIO)|Salarius - Pangali Forward P/E|Kitov Pharma (PPBT) - Prakiraan rega marang bathi|aoncology.com (AONC) - Rega marang bathi mangsa ngarep|BGNE - Kapitalisasi marang proyeksi bathi|CKPT (Checkpoint Therapeutics, Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi elevationoncology.com (ELEV)|Pangali Forward P/E ICAD|Pangali Forward P/E ikenaoncology.com (IKNA)|Pangali Forward P/E NTBL (Notable Labs, Ltd.)|VIRX: Rasio rega marang bathi mangsa ngarep|MOR - Rega marang bathi mangsa ngarep|NAYA: Rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E
